These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 38216787)

  • 1. Immunosurveillance encounters cancer metabolism.
    Chuang YM; Tzeng SF; Ho PC; Tsai CH
    EMBO Rep; 2024 Feb; 25(2):471-488. PubMed ID: 38216787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.
    Sung JY; Cheong JH
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoediting instructs tumor metabolic reprogramming to support immune evasion.
    Tsai CH; Chuang YM; Li X; Yu YR; Tzeng SF; Teoh ST; Lindblad KE; Di Matteo M; Cheng WC; Hsueh PC; Kao KC; Imrichova H; Duan L; Gallart-Ayala H; Hsiao PW; Mazzone M; Ivanesevic J; Liu X; de Visser KE; Lujambio A; Lunt SY; Kaech SM; Ho PC
    Cell Metab; 2023 Jan; 35(1):118-133.e7. PubMed ID: 36599297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer.
    Audrito V; Managò A; Gaudino F; Sorci L; Messana VG; Raffaelli N; Deaglio S
    Front Immunol; 2019; 10():1720. PubMed ID: 31402913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer metabolic reprogramming and immune response.
    Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
    Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma.
    Rana PS; Goparaju K; Driscoll JJ
    Front Oncol; 2023; 13():1141851. PubMed ID: 37361580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses.
    Huldani H; Malviya J; Rodrigues P; Hjazi A; Deorari MM; Al-Hetty HRAK; Qasim QA; Alasheqi MQ; Ihsan A
    Cell Biochem Funct; 2024 Mar; 42(2):e3934. PubMed ID: 38379261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
    Sheppard AD; Lysaght J
    Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating T-cell metabolism to enhance immunotherapy in solid tumor.
    Chen C; Wang Z; Ding Y; Qin Y
    Front Immunol; 2022; 13():1090429. PubMed ID: 36618408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fueling influenza and the immune response: Implications for metabolic reprogramming during influenza infection and immunometabolism.
    Bahadoran A; Bezavada L; Smallwood HS
    Immunol Rev; 2020 May; 295(1):140-166. PubMed ID: 32320072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review).
    Li X; Xu W
    Oncol Rep; 2019 May; 41(5):2945-2956. PubMed ID: 30864716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.
    Li F; Simon MC
    Dev Cell; 2020 Jul; 54(2):183-195. PubMed ID: 32640203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
    Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
    Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
    Smyth MJ; Dunn GP; Schreiber RD
    Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
    Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response.
    Cassim S; Pouyssegur J
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.